News & Events
A new study by Thomas Jefferson University neuroscientist Jay Schneider, PhD, suggests that the toxic effects of lead can be mitigated by attentive maternal care and an enriched environment in an animal model.
A new study led by Thomas Jefferson University researchers has revealed insights into how the eye handles inflammation, particularly in autoimmune uveitis, an inflammatory disease that bypasses the eye’s immune privilege and can damage healthy eye tissue.
In their recent study, Danielle M. Tholey, MD and her team at Thomas Jefferson University wanted to identify why men seem to be receiving more liver transplants than women. They looked at race, sex, insurance and education of patients receiving liver transplants. They then grouped the patients by whether they received a liver transplant from a deceased donor or a living donor.
Silva Markovic-Plese, MD, PhD and her team at Thomas Jefferson University have been studying RRMS for more than a decade. In a previous study, they noticed elevated levels of an immune chemical called, IL-11, in the cerebrospinal fluid surrounding the brain and spinal cord of RRMS patients. They wanted to explore why.
